Galderma Group AG
Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
- Conditions
- Interventions
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2022-08-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 75
- Registration Number
- NCT01046565
- Locations
- 🇺🇸
Thomas J. Stephens & Associates, Inc., Carrollton, Texas, United States
Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
- Conditions
- Interventions
- First Posted Date
- 2010-01-12
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 69
- Registration Number
- NCT01046396
- Locations
- 🇺🇸
Thomas J. Stephens & Associates, Inc., Colorado Springs, Colorado, United States
Comparison of Two Botulinum Toxins Type A on Forehead Wrinkles
- Conditions
- Interventions
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 30
- Registration Number
- NCT01014871
- Locations
- 🇩🇪
La Charité Hospital, Berlin, Germany
Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2009-11-17
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 378
- Registration Number
- NCT01014689
- Locations
- 🇸🇪
Galderma Investigator site, Hagersten, Sweden
Gene Expression in Renal Transplant Patients With Field Actinic Keratosis Undergoing Metvix® Photodynamic Therapy (PDT)
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 9
- Registration Number
- NCT01000636
- Locations
- 🇬🇧
Department of Dermatology of Manchester Royal Infirmary, Manchester, United Kingdom
Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2022-08-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 138
- Registration Number
- NCT00988637
- Locations
- 🇺🇸
Dermatology Research Associates, Los Angeles, California, United States
🇺🇸Minnesota Clinical Study Center, Fridley, Minnesota, United States
🇺🇸Hudson Dermatology, Evansville, Indiana, United States
Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea
- Conditions
- Interventions
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 122
- Registration Number
- NCT00989014
- Locations
- 🇺🇸
Derm Research, Inc, Austin, Texas, United States
🇺🇸Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇺🇸The Education & Research Foundation, Lynchburg, Virginia, United States
Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins
- First Posted Date
- 2009-09-03
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 30
- Registration Number
- NCT00971282
- Locations
- 🇸🇬
national Skin Center, Singapore, Singapore
Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis
- Conditions
- First Posted Date
- 2009-07-17
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 25
- Registration Number
- NCT00941317
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With Macrolane
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 10
- Registration Number
- NCT00931268
- Locations
- 🇫🇷
Henri Mondor Hospital, Créteil, France